Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays
Authors:
- Beatrice E. TyrrellBTBeatrice E. Tyrrell
- Abhinav KumarAKAbhinav Kumar
- Bevin GangadharanBGBevin Gangadharan
- Dominic AlonziDADominic Alonzi
- Juliane BrunJBJuliane Brun
- Michelle HillMHMichelle Hill
- Tehmina BharuchaTBTehmina Bharucha
- Andrew BosworthABAndrew Bosworth
- Victoria GrahamVGVictoria Graham
- Stuart DowallSDStuart Dowall
- Joanna L. MillerJMJoanna L. Miller
- Nicole ZitzmannNZNicole Zitzmann
Open Access
Abstract
Crimean-Congo haemorrhagic fever virus (CCHFV) is a pathogen of increasing public health concern, being a widely distributed arbovirus and the causative agent of the potentially fatal Crimean-Congo haemorrhagic fever. Hazara virus (HAZV) is a genetically and serologically related virus that has been proposed as a surrogate for antiviral and vaccine testing for CCHFV. Glycosylation analysis of HAZV has been limited; first, we confirmed for the first time the occupation of two N-glycosylation sites in the HAZV glycoprotein. Despite this, there was no apparent antiviral efficacy of a panel of iminosugars against HAZV, as determined by quantification of the total secretion and infectious virus titres produced following infection of SW13 and Vero cells. This lack of efficacy was not due to an inability of deoxynojirimycin (DNJ)-derivative iminosugars to access and inhibit endoplasmic reticulum α-glucosidases, as demonstrated by free oligosaccharide analysis in uninfected and infected SW13 and uninfected Vero cells. Even so, iminosugars may yet have potential as antivirals for CCHFV since the positions and importance of N-linked glycans may differ between the viruses, a hypothesis requiring further evaluation.Keywords
Funding Information
- Wellcome Trust (105402/Z/14/Z, MR/N013468/1)
- Oxford Glycobiology Endowment (105402/Z/14/Z, MR/N013468/1)
- Medical Research Council (105402/Z/14/Z, MR/N013468/1)
This publication has 56 references indexed in Scilit:
- In silico Platform for Prediction of N-, O- and C-Glycosites in Eukaryotic Protein SequencesPLOS ONE, 2013
- Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirinVirology Journal, 2011
- Ribavirin for patients with Crimean–Congo haemorrhagic fever: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2011
- Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse ModelJournal of Virology, 2010
- Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysisBMC Infectious Diseases, 2010
- A novel nucleoside analog, 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitroAntiviral Research, 2010
- Crimean-Congo Hemorrhagic Fever Virus Genomics and Global DiversityJournal of Virology, 2006
- Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharidesGlycobiology, 1994
- Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues.Journal of Cell Biology, 1992
- Structural Polypeptides of Hazara VirusJournal of General Virology, 1981